Repository logo
Andean Publishing ↗
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Autor "Daniela Duran-Moreno"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item type: Item ,
    Clinical Results of the Use of a Combined Solution of Carboxymethylcellulose 0,5%, Glycerin 0,9% and Trehalose 3% for the Treatment of Dry Eye Disease
    (Research Square (United States), 2023) Pedro-Ivan Navarro-Naranjo; Alberto Chacon-Aponto; Gerardo Artunduaga-Rodriguez; Daniela Duran-Moreno
    Abstract Objective: To describe the clinical effects of a novel combined ocular lubricant for treating patients with dry eye disease. Methods : A retrospective cohort of 67 eyes (67 patients) with a confirmed diagnosis of dry eye disease using the ocular surface disease index (>12), tear osmolarity and ocular surface parameters (non-invasive break-up time, meniscus height and meibography) evaluated using the Cornea550 were included. All patients were treated with a combination of 0.5% carboxymethylcellulose, glycerin 0.9% and trehalose 3% with a dosing regimen of one drop four times a day for one month with a final evaluation of the same parameters. Results : We included 67 eyes (80.6% females) with a mean age of 48.3+/-16.2 years (SD). 37% of the subjects had comorbidities such as hypothyroidism (9%), ocular rosacea (4%), Sjogren’s syndrome (4%) and arterial hypertension (4%). Of these, 34% were taking systemic medications and 56.7% had previous ocular surgery. The mean OSDI score before treatment was 57.6 +/- 17.2 (SD) and 22.2 +/-12.9 points (SD) after treatment ( p <0.05). Other parameters such as NIBUT, meniscus height and meibography improved without a statistically significant difference. Conclusion: CTP is a novel, combined and multipurpose treatment for dry eye disease.

Andean Library © 2026 · Andean Publishing

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback